banner add

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT

No comments

A New Drug Lifts the Fog of Sleepiness for Those With Narcolepsy

The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. from NYT > Health https://ift.tt...

Theme images by PLAINVIEW. Powered by Blogger.